Basal Cell Carcinoma

NEW ORLEANS — A machine learning algorithm was able to differentiate between basal cell and squamous cell carcinomas by identifying biomarkers, according to a poster presented here.

CHICAGO — OCT accurately staged skin cancers, allowing for better diagnosis of basal cell carcinoma, prediction of margins and improved planning for Mohs surgery, according to a study presented here.

MILAN — Patients who underwent re-excision for positive margins after incomplete surgery for basal cell carcinoma had significantly lower recurrence rates than those who were followed up clinically, according to a poster presented here.

OCT-guided and temperature-controlled hyperthermic treatment could be a safe, noninvasive alternative to surgical tumor removal in superficial basal cell carcinoma, according to a presentation of preliminary data.

A portable photodynamic therapy device for at-home treatment of basal cell carcinoma was shown to be efficacious in a pilot study presented at the EADV virtual congress.

Frailty and comorbidities were some of the patient-related factors that drove patients to choose a watchful waiting approach to basal cell carcinoma, according to a study.

Metformin, even in low doses, may be associated with a decreased risk for basal cell carcinoma, according to a study.

Sonidegib efficacy in patients with locally advanced basal cell carcinoma was not affected by concomitant cardiovascular medications, according to a presentation at Maui Derm for Dermatologists.

The FDA granted regular approval to cemiplimab-rwlc for patients with locally advanced basal cell carcinoma who were previously treated with or ineligible for treatment with a hedgehog pathway inhibitor.

Patients with basal cell carcinoma who discontinued hedgehog inhibitors had differing odds for reinitiation that varied by grace period, according to a presentation at Maui Derm for Dermatologists.